BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//wp-events-plugin.com//7.2.3.1//EN
BEGIN:VEVENT
UID:7970@myasthenia.org
DTSTART;TZID=America/New_York:20251022T140000
DTEND;TZID=America/New_York:20251022T150000
DTSTAMP:20251006T165431Z
URL:https://myasthenia.org/events/webinar-pioneering-rna-cell-therapy-for-
 autoimmune-diseases/
SUMMARY:Webinar: Pioneering RNA Cell Therapy for Autoimmune Diseases
DESCRIPTION:\nWednesday\, October 22\, 2025 2:00 PM Eastern Time / 11:00 AM
  Pacific Time\n\n\n\nPresenters:\n\n\n\nDr. Milos Miljkovic – Chief Medi
 cal Officer\, Cartesian Therapeutics \n\n\n\nDescartes-08 is an RNA ce
 ll therapy designed to target immune cells which produce autoantibodies di
 rectly responsible for symptoms of myasthenia gravis and other autoimmune 
 diseases. In a Phase 2b randomized controlled trial in adults with general
 ized myasthenia gravis\, participants who received Descartes-08 had signif
 icant improvement in symptoms compared to placebo\, which was maintained t
 hrough 12 months of follow-up. In this webinar\, we will discuss the resul
 ts of this recently completed trial\, as well as the ongoing Phase 3 trial
  of Descartes-08 in MG (AURORA). \n\n\n\nRegister\n\n\n\nAfter registerin
 g\, you will receive a confirmation email containing information about joi
 ning the webinar.\n
ATTACH;FMTTYPE=image/jpeg:https://myasthenia.org/wp-content/uploads/2025/1
 0/Miljkovic-thumbnail.png
CATEGORIES:Events
END:VEVENT
BEGIN:VTIMEZONE
TZID:America/New_York
X-LIC-LOCATION:America/New_York
BEGIN:DAYLIGHT
DTSTART:20250309T030000
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
END:DAYLIGHT
END:VTIMEZONE
END:VCALENDAR